19
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Exploring Magnesium Myristate for Its Dual Functionality as a Binder and Lubricant in the Formulation of Tablet

, ORCID Icon, , &
Pages 253-266 | Received 10 Oct 2023, Accepted 16 Feb 2024, Published online: 29 Feb 2024

References

  • Milanesi M , RunfolaA, GuerciniS. Pharmaceutical industry riding the wave of sustainability: review and opportunities for future research. J. Clean. Prod.261(10), 121204 (2020).
  • Bhatia V , DhingraA, ChopraB, GuarveK. Co-processed excipients: recent advances and future perspective. J. Drug Deliv. Sci. Technol.71, 103316 (2022).
  • Zaid AN . A comprehensive review on pharmaceutical film coating: past, present, and future. Drug Des. Devel. Ther.14, 4613–4623 (2020).
  • Rayaprolu M , StrawserJ, AnyarambhatlaG. Excipients in parenteral formulations: selection considerations and effective utilization with small molecules and biologics. Drug Dev. Ind. Pharm.44(10), 1565–1571 (2018).
  • Shah H , JainA, LaghateG, PrabhudesaiD. Pharmaceutical Excipients. In: Remington – The Science and Practice of Pharmacy.Academic Press, London, UK, 633–643 (2021).
  • Pockle R , MasareddyR, PatilA, PatilP. A comprehensive review on pharmaceutical excipients. Ther. Deliv.14(7), 1–17 (2023).
  • Kyriakopoulou K , KepplerJK, vander Goot AJ. Functionality of ingredients and additives in plant-based meat analogues. Foods.10(3), 600 (2021).
  • Zarmpi P , FlanaganT, MeehanE, MannJ, FotakiN. Biopharmaceutical understanding of excipient variability on drug apparent solubility based on drug physicochemical properties. case study: superdisintegrants. AAPS J.22(46), 1–17 (2020).
  • Bin LK , GauravA, MandalUK. A review on co-processed excipients: current and future trend of excipient technology. Int. J. Pharm. Pharm. Sci.11(1), 1–9 (2019).
  • Sierra-Vega O , KarryK, RomanachR, MéndezR. Monitoring of high-load dose formulations based on co-processed and non co-processed excipients. Int. J. Pharm.606, 120910 (2021).
  • Van der Merwe J , SteenekampJ, SteynD, HammanJ. The role of functional excipients in solid oral dosage forms to overcome poor drug dissolution and bioavailability. Pharmaceutics.12(5), 393 (2020).
  • Hamman J , SteenekampJ. Excipients with specialized functions for effective drug delivery. Expert. Opin. Drug Deliv.9(2), 219–230 (2012).
  • Patel H , GohelM. A review on development of multifunctional co-processed excipient. J. Crit. Rev.3(2), 48–54 (2016).
  • Zhao T , KangZ. Simultaneously fabricating multifunctional superhydrophobic/superoleophilic coatings by one-step electrodeposition method on cathodic and anodic magnesium surfaces. J. Electrochem. Soc.163(10), D628–D635 (2016).
  • Becker L , BergfeldW, BelsitoDet al. Final report of the amended safety assessment of myristic acid and its salts and esters as used in cosmetics. Int. J. Toxicol.29(S3), 1625–1865 (2010).
  • Jain S , RathiR, NagaichU, SinghI. Co – processed tablet excipient composition, its preparation and use. Pharm. Pat. Anal.12(1), 19–25 (2022).
  • Deshmukh MT , KoreVU, KshirsagarPK, JagtapSV, SheteRV. Formulation and evaluation of sustained release matrix tablet of metformin hydrochloride. J. Curr. Pharma. Res.8(3), 2403–2412 (2018).
  • Maram E , SolluJ. Formulation and in vitro evaluation of metformin hydrochloride sustained release tablets. J. Drug Del. Ther.9(4), 24–29 (2019).
  • Sandhan S , DerleD. A review on functionality assessment of multifunctional excipients. Int. J. Pharm. Sci. Res.10(9), 4078–4089 (2019).
  • Aleti R , BaratamSR, JagirapuB, KudamalaS. Formulation and evaluation of Metformin Hydrochloride and Gliclazide sustained release bilayer tablets: a combination therapy in management of diabetes. Int. J. Appl. Pharm.13(5), 343–350 (2021).
  • Bowles J , DziemidowiczK, LopezFet al. Co-processed excipients for dispersible tablets–part 1: manufacturability. AAPS PharmSciTech.19, 2598–2609 (2018).
  • Chauhan I , NathwaniV, SoniwalaM, ChavdaR. Development and characterization of multifunctional directly compressible co-processed excipient by spray drying method. AAPS PharmSciTech.18(4), 1293–1301 (2017).
  • Janssen H , DepaifveS, NeveuA, FrancquiF, DickhoffH. Impact of powder properties on the rheological behavior of excipients. Pharmaceutics.13(8), 1198 (2021).
  • Bardestani R , PatienceS, KaliaguineS. Experimental methods in chemical engineering: specific surface area and pore size distribution measurements–BET, BJH, and DFT. Can. J. Chem. Eng.97(11), 2781–2791 (2019).
  • Thao H , TruongT, BhandariB. Methods to characterize the structure of food powders–a review. Biosci. Biotechnol. Biochem.81(4), 651–671 (2017).
  • Jendrzejewska I , ZajdelP, PietrasikE, BarsovaZ, GoryczkaT. Application of X-ray powder diffraction and differential scanning calorimetry for identification of counterfeit drugs. Monatsh. Chem.149, 977–985 (2018).
  • Thapa P , TripathiJ, JeongH. Recent trends and future perspective of pharmaceutical wet granulation for better process understanding and product development. Powder Technol.344, 864–882 (2019).
  • Chelladurai SJ , MuruganK, RayAP, UpadhyayaM, NarasimharajV, GnanasekaranS. Optimization of process parameters using response surface methodology: a review. Mater. Today: Proc.37(2), 1301–1314 (2021).
  • Arafat M , SakkalM, YuvarajuP, EsmaeilA, PouloseV, AburuzS. Effect of Excipients on the Quality of Drug Formulation and Immediate Release of Generic Metformin HCl Tablets. Pharmaceuticals16(4), 539 (2023).
  • Kim KM . Design of experiments for critical material attributes assessment of linagliptin and metformin fixed-dose combination tablets. Indian J. Pharm. Educ. Res.55, 701–708 (2021).
  • Khan J , KusmahaniSH, RuhiSet al. Design and evaluation of sustained release matrix tablet of flurbiprofen by using hydrophilic polymer and natural gum. Int. J. Med. Toxicol. Leg. Med.23(1 and 2), 149–159 (2020).
  • Singh B , SainiG, VyasM, VermaS, ThakurS. Optimized chronomodulated dual release bilayer tablets of fexofenadine and montelukast: quality by design, development and in vitro evaluation. Future J. Pharm. Sci.5(6), 1–20 (2019).
  • Bookya P , RaparlaR, SriramulaHP, TarrigopulaS, VangaS. Formulation and evaluation of Metformin HCl sustained release oral matrix tablets. Asian J. Pharm. Clin. Res.11(2), 342–345 (2018).
  • Alam A , BishalM, BandyopadhyayR. Formulation and evaluation of metformin hydrochloride sustained release matrix tablets. Int. J. Curr. Pharm.13(5), 82–88 (2021).
  • Jakubowska E , CiepluchN. Blend segregation in tablets manufacturing and its effect on drug content uniformity—a review. Pharmaceutics13(11), 1909 (2021).
  • Ilyés K , AttilaB, TiborCet al. 3D floating tablets: appropriate 3D design from the perspective of different in vitro dissolution testing methodologies. Int. J. Pharm.567, 118433 (2019).
  • Jamei M , AbrahamssonB, BrownJet al. Current status and future opportunities for incorporation of dissolution data in PBPK modeling for pharmaceutical development and regulatory applications: orBiTo consortium commentary. Eur. J. Pharm. Biopharm.155, 55–68 (2020).
  • Kakad SB , RachhPR. Effect of hydrophilic polymer and binder on drug release of metformin HCl sustained release tablet. Int. J. Health Sci.6(S3), 3343–6635 (2022).
  • González-González O , RamirezI, RamirezBet al. Drug stability: ich versus accelerated predictive stability studies. Pharmaceutics.14(11), 2324 (2022).
  • Yasmeen A , SofiG. A review of regulatory guidelines on stability studies. J. phytopharm.8(3), 147–151 (2019).
  • Teja B , PatilP, SheteG, PatelS, BansalK. Drug-excipient behavior in polymeric amorphous solid dispersions. J. Excip. Food Chem.4(3), 70–94 (2016).
  • Balpande M , RautS, UmekarJ, KotagaleR. Compatibility study of metformin with pharmaceutical excipients. Int. J. Chem. Tech. Res.5(4), 1684–1693 (2013).
  • Kakad B , RachhR. Effect of hydrophilic polymer and binder on drug release of metformin HCl sustained release tablet. Int. J. Health Sci.6(S3), 3343–6635 (2022).
  • Ancudumitrascu P , GabrielastecozaC, PopaMVet al. The impact of the lubrication step with magnesium stearate on the Quality Target Product Profile of a modified release oral dosage form containing a BCS class II active pharmaceutical ingredient. Farmacia.68(3), 526–531 (2020).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.